Could Big Pharma Answer The Call From Chinese Health Insurers For Big Data?
This article was originally published in PharmAsia News
Executive Summary
Chinese insurers are challenged by limited information and actuarial expertise, providing an opportunity for pharma companies to help build the private market, industry insiders say.